US Patent 7740843 Human monoclonal antibodies against human IL-4
Patent 7740843 was granted and assigned to Novartis on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+137 characters)
Article
Patent abstract
Antibodies which are specific for human interleukin-4 and their use in the treatment of IL-4 and/or IgE mediated diseases.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Christoph Schwaerzler0
Jan E. De Vries0
José M. Carballido Herrera0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07740843 Human monoclonal antibodies against human IL-4 US Patent 7740843 Human monoclonal antibodies against human IL-4
Infobox
Patent Number
077408430
Patent Number
77408430
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077408430
Date of Patent
June 22, 2010
0Patent Application Number
116329390
Date Filed
August 2, 2005
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07740843 Human monoclonal antibodies against human IL-4
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07740843
Date of patent
June 22, 2010
Patent application number
11632939
Date Filed
August 2, 2005
Patent primary examiner
Find more entities like US Patent 7740843 Human monoclonal antibodies against human IL-4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
